Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
-
GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"
-
Portrait Bank Earns Coveted State Charter Ahead of Upcoming Grand Opening
-
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
-
HealthLynked Launches AI-Powered Healthcare Communication Platform Featuring 24/7 Appointment Scheduling and Medical Office AI Agents
-
XMax Inc. Added to Russell 3000® Index
-
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
-
SureView Systems Acquired by Volaris Group
-
Music Circus to Drive TryHard Holdings’ Expansion in Cultural Programming and Nationwide Events with SBI Holdings
-
Music Circus to Drive TryHard Holdings’ Expansion in Cultural Programming and Nationwide Events with SBI Holdings
-
Abundia Global Impact Group Announces Inclusion in Russell Microcap® Index
-
Roadzen Delivers Best Quarter in Company History with Q4 FY2026 Revenue of $16.1 Million, Up 42% Year-Over-Year; Record Full-Year Revenue of $55.0 Million, Up 24%
-
Kaltura Recognized in the 2026 Gartner® Market Guide for Video Platform Services
-
Treno Scope CEO Issues Statement on Southeast Asia Data Sovereignty Product Roadmap
-
LanzaTech Announces Inclusion in the Russell 3000® Index
-
Village Farms Netherlands Launches Limited-Edition WK Duo-Pack Pre-Roll
-
Swarmer Adds Additional $1M in Revenue From SkyKnight Contract Update That Expands Swarming Software To Czech Republic
-
OPT Extends Its Section 382 Tax Benefits Preservation Plan
-
HyOrc Corporation Profiled by Lux Research, Validating Disruptive Green Methanol Production Economics
-
New Survey: Beer Tops List of Drinks Adults Consider Most American
-
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
-
Ascent Solar’s Thin-Film Space Solar Products Experience Zero Damage in Atomic Oxygen Exposure Test Campaign
-
Nasdaq Halts Happy City Holdings Ltd
-
CSL Advances on ESG Goals in 2025 Sustainability Report
-
DeFi Development Corp. Provides Update on DeFi Development Corporation UK PLC
-
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
-
Skanska USA Building Appoints Bryan Northrop as General Manager of its Advanced Technology Operating Unit
-
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
-
Kaltura Recognized in the 2026 Gartner® Market Guide for Video Platform Services
-
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes
-
Block & Leviton LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Biogen, Inc. – BIIB
-
Kalmar secures new orders for electric reachstackers from customers across China
-
Pasqal Appoints Stéphane Rougeot as Chief Financial Officer
-
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
-
Latin Metals Reports High-Grade Gold Results at La Flora
-
Correction: VivoPower Selects Global AI Industry Leader as Preferred Tenant for Lease of Norway Operational Data Center
-
Brera Holdings Board Survives Re-Election Only After Counting Shares Issued to Itself in Contested RDO; External Shareholders Voted the Board Out
-
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
-
VOKA 3D Anatomy & Pathology Expands Free Access to the Entire 3D Model Library
-
VOKA 3D Anatomy & Pathology Expands Free Access to the Entire 3D Model Library
-
Almadex Announces Sale of El Cobre NSR Royalty
-
BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
-
Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes
-
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
-
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
-
FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes
-
AVANTE ANNOUNCES AGREEMENT WITH TARGET PARK TO DEPLOY MAST UNITS IN ABOVE-GROUND PARKING FACILITIES ACROSS CANADA AND THE UNITED STATE
-
FuelCell Energy Secures $49 Million in EXIM Financing to Advance U.S. Clean Energy Exports
-
Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO
-
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
